Food and Gastrointestinal Habits After Bariatric Surgery

NCT ID: NCT01224054

Last Updated: 2010-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

34 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The worldwide epidemic of overweight and obesity affects about 1.7 billion people around the world. Since 1991, many international medical societies have established as recommendation for bariatric surgery the unsuccessful clinical treatment in patients with IMC \> 40Kg/m2 or IMC \> 35Kg/m2 in the cases with serious co-morbidities related to the possible reversion of them with the lose of weight due to the surgery. In front of the new anatomical condition from the gastrointestinal tract the patients present changes in food preferences and in the food intake, which include modifications in food choices, perception of hungry and satiety and in the tolerance to determinate food. These changes in food intake of the patients are observed mostly in the first year after the surgery an adaptive phase to a new condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After the new anatomical condition of the gastrointestinal tract, provided by bariatric surgery leads patients to experience changes in food intake and behavior. The aim of this study was to assess alimentary habits, food intolerances and gastrointestinal symptoms in patients who underwent bariatric and metabolic procedures: Roux-en-Y gastric bypass, biliopancreatic diversion and duodenal exclusion. We studied 34 patients of both sexes, from outpatient clinics in Surgery of Obesity and the Metabolic Surgery at University of Campinas. They were submitted to bypass gastric in Roux-en-Y (n=15), biliopancreatic diversion (n=9) and duodenal exclusion (n=10). Validated questionnaire for assessment of food tolerance was applied in patients with more than six months of follow-up after surgery addressing diet and gastrointestinal symptoms. The descriptive and comparative analyses were performed by analysis of variance and bivariate correlation. In patients who underwent to bypass gastric food intolerance was greats regarding to ingestion of rice (33%) and red meat (33%) in comparison to others groups. The flatulence and diarrhea were more prevalent in patients who underwent biliopancreatic diversion. The vomiting was more prevalent in patients who underwent gastric bypass. Each procedure presents peculiarities to the anatomical and functional changes that affect the food absorption. This may have negative effects on the nutritional status of patients and affect the quality of life. The nutritional therapy for each individual procedure may assist in the management of clinical concerns of operated patients

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgeries

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bypass gastric

The mixed surgery which combine the gastric reduction with some degree of disabsorption

No interventions assigned to this group

Biliopancreatic diversion

The mal-absorptive surgery which reduce the intestinal absorption of food

No interventions assigned to this group

Duodenal exclusion

This surgery provides disabsortion by duodenal derivation maintaining an intact stomach

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients submitted of bypass gastric, biliopancreatic diversion and duodenal exclusion

Exclusion Criteria

* Presenting no diseases that could compromise their nutritional status, such as liver disease, kidney or cancer.
Minimum Eligible Age

24 Years

Maximum Eligible Age

62 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Campinas, Brazil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Campinas, Brazil (UNICAMP)

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruno Geloneze

Role: PRINCIPAL_INVESTIGATOR

University of Campinas (UNICAMP)

Daniela Tezoto

Role: STUDY_CHAIR

+55-19-3521-8589

Éliton Chaim

Role: STUDY_CHAIR

University of Campinas (UNICAMP)

Marcelo Lima

Role: STUDY_CHAIR

University of Campinas (UNICAMP)

Sylka Geloneze

Role: STUDY_CHAIR

University of Campinas (UNICAMP)

José Carlos Pareja

Role: STUDY_CHAIR

University of Campinas (UNICAMP)

Vanessa Coutinho

Role: STUDY_CHAIR

Gama Filho University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LIMED - Laboratory of Investigation on Metabolism and Diabetes/Gastrocentro/University of Campinas (UNICAMP)

Campinas, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEP 289/2008

Identifier Type: OTHER

Identifier Source: secondary_id

LIMED0009

Identifier Type: -

Identifier Source: org_study_id